TWIST1 and prostate carcinoma: Several reports have indicated that Twist is the key regulator of the EMT process associated with tumor cell proliferation, differentiation, metastasis, invasion and anti-apoptotic process, with clinical implication of poor prognosis and metastasis in many kinds of cancers, such as breast, esophageal, gastric and prostate cancer.